Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Streamlined EU Supplementary Protection Certificate System Moves Ahead

Executive Summary

A parliamentary committee says the proposals will remove the fragmentation in the EU SPC system and bring predictability for both the innovative and generics industry.

You may also be interested in...



EU’s Unitary SPC System Must Maximize Access To Medicines And Not Block Generic Entry

A European Parliament committee says that some aspects of the EU’s proposed unitary supplementary protection certificate scheme could promote access to cheaper off-patent medicines while others could delay generic competition.

EU’s Unitary SPC System Must Maximize Access To Medicines & Not Block Generic Entry

A European Parliament committee says that some aspects of the EU’s proposed unitary supplementary protection certificate scheme could promote access to cheaper off-patent medicines while others could delay generic competition.

EU-Wide Compulsory Licensing Plan Draws R&D Industry Ire

The European Commission says its proposals on EU-level compulsory licensing and a unitary supplementary protection certificate will create a more efficient and future-proof framework for intellectual property rights.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB153261

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel